Does the standardized VISITAG SURPOINT ablation workflow provide clinical safety and effectiveness in patients with paroxysmal atrial fibrillation?
The VISITAG SURPOINT module for paroxysmal AF ablation demonstrates >80% 12-month freedom from recurrence and an 83.1% first-pass isolation rate.
The VS postapproval study confirms reproducibility of clinical safety and effectiveness of the standardized VS paroxysmal atrial fibrillation ablation workflow with >80% 12-month freedom from atrial tachyarrhythmia recurrence and first-pass isolation rate of 83.1%. Procedures were performed with minimal fluoroscopy. (Evaluation of VISITAG SURPOINT™ Module With External Processing Unit EPU; NCT03624881).
Biase et al. (Wed,) studied this question.